ArticleEsophagus : official journal of the Japan Esophageal Society2026
Estimation of esophageal involvement length in esophagogastric junction tumors using PET-CT.
Article in Esophagus : official journal of the Japan Esophageal Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEsophageal involvement length (EIL) is crucial to determining the surgical strategy for esophagogastric junction (EGJ) tumors. This study developed a positron emission tomography-computed tomography (PET-CT)-based method using anatomical landmarks to estimate EIL and evaluated the clinical utility of the model.
methodsWe enrolled 50 patients with EGJ adenocarcinoma who underwent surgical resection. Among patients who underwent upfront surgery (Cohort 1, n = 24), craniocaudal distances were measured from the right and left diaphragms and vena cava foramen (VCF) to the proximal tumor margin on PET-CT images and correlated with histological EIL to establish the best-performing model. Predictive ability was validated in patients who underwent surgery after neoadjuvant chemotherapy (Cohort 2, n = 26).
resultsIn Cohort 1, among the three anatomical landmarks, VCF most strongly correlated with histological EIL (r = 0.81), providing the following formula: Predicted EIL (mm) = 22 + 0.3 × [Craniocaudal distance from VCF to proximal tumor margin (mm)]. The median absolute difference between the histological and predicted EILs was 4.6 mm (interquartile range, 1.6-6.3 mm), with 96% of cases (23/24) within 10 mm. Evaluation of the model in Cohort 2 found r = 0.81, a median absolute difference of 3.3 mm (interquartile range, 1.1-7.2 mm), and 92% of cases (24/26) within 10 mm. Predictive errors were significantly smaller in both cohorts than in endoscopic findings (Cohort 1, P = 0.004; Cohort 2, P = 0.002).
conclusionsA PET-CT-based approach using the craniocaudal distance from the VCF to the proximal margin could estimate EIL with sufficient accuracy to support surgical decision-making in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.